Loading field map
One Health is both a scientific subfield and a collaborative movement that starts from a single, deceptively simple observation: the health of humans, domestic and wild animals, and ecosystems is not separable. Diseases move across species boundaries; environmental change alters the conditions under which those movements happen; and the institutions built to protect health—human medicine, veterinary medicine, environmental management—have historically been organized as if these boundaries were real. One Health is the sustained attempt to understand and act on their interconnection.
In practice, this means studying zoonotic diseases (infections transmitted between animals and humans), comparing disease processes across species, tracking how land use, climate, and agricultural practices influence pathogen emergence, and designing surveillance, response, and prevention systems that do not stop at the species line. The field’s central question is not simply “What diseases do animals give people?” but the broader one: How do the healths of all three domains co-produce each other, and how can knowledge and institutions be reorganized to reflect that? Its stakes are correspondingly high: most emerging infectious diseases in humans are zoonotic in origin, and the costs of failing to anticipate or contain them are measured in lives, livelihoods, and the erosion of health systems.
The recognition that human and animal health are linked is ancient. Agrarian and pastoral societies observed that sick livestock could sicken people, and healers of humans and animals often drew on the same humoral and empirical frameworks. In the nineteenth century, the rise of microbiology gave this observation a mechanistic basis. The discovery of Bacillus anthracis and the development of vaccines against anthrax and rabies—work in which the physician Robert Koch and the veterinarian Henri Bouley both played roles—demonstrated that specific pathogens could circulate between species and that controlling a disease in animals could prevent it in humans.
This was not yet One Health as a self-conscious program. Nineteenth- and early twentieth-century comparative medicine, veterinary public health, and tropical medicine were precursors, not members, of the modern field. They shared One Health’s conviction that species boundaries are porous to disease, but they were institutionally and conceptually separate: veterinary medicine was largely oriented to livestock productivity and state animal health, and human medicine to clinical care and epidemic control. The term “One Health” itself is a modern coinage, often traced to the early 2000s, though its immediate antecedent, “One Medicine,” was promoted by the epidemiologist Calvin Schwabe in the 1960s and 1970s. Schwabe argued that human and veterinary medicine were a single discipline with different patient populations—a unificationist vision that remains influential within the field, though One Health has since broadened well beyond clinical medicine.
The modern formulation gained urgency from a series of late-twentieth-century events: the emergence of HIV/AIDS (likely a zoonosis from nonhuman primates), the 1994 outbreak of pneumonic plague in India, the 1997 and later H5N1 avian influenza outbreaks, and the 2003 SARS epidemic. Each of these demonstrated that emerging infectious disease could not be understood or contained by human medical surveillance alone. They also revealed a structural gap: when a pathogen jumps from wildlife to livestock to people, the relevant expertise is scattered across ministries of health, agriculture, and environment, which often do not share data or coordinate responses. One Health emerged as both a scientific research program and an institutional reform movement designed to close that gap.
At its most basic, One Health is an ecological science. It asks where pathogens live, how they move, and what conditions allow them to cross species barriers. The central biological entities are reservoir hosts (species that maintain a pathogen without severe disease, such as bats and certain rodents for many coronaviruses and filoviruses), spillover events (individual transmissions from reservoir to new host), and amplifying hosts (often domesticated animals, in which a pathogen multiplies sufficiently to reach human populations). The field also tracks vectors—ticks, mosquitoes, fleas—that can carry pathogens across species regardless of direct contact.
This ecological perspective is inseparable from an evolutionary one. A pathogen’s ability to infect a new host depends on molecular features—for example, whether a viral surface protein can bind to a receptor present in the new host’s cells. One Health investigates how mutation and recombination create such abilities, and how selection acts once a pathogen has entered a new species. A key concept is pathogen emergence: species jumps that are not merely one-off accidents or dead-end infections, but that establish sustained transmission in the new host population. The difference between a spillover and an emergence is often a small number of mutations, which makes the evolutionary dynamics of pathogens a matter of direct practical importance.
Comparative biology supplies the third leg. Many pathogens cause similar diseases across species, but the details differ: a virus that is lethal in humans may be asymptomatic in its reservoir host; a bacterium that causes mild diarrhea in cattle can cause life-threatening disease in people. Comparative medicine studies these differences to understand pathogenesis—how a pathogen causes disease at the cellular and physiological level—and to evaluate whether animal models (carefully regulated and increasingly supplemented by other methods) can inform human treatment. Conversely, veterinary clinical practice feeds observations of unusual animal disease into human health surveillance, as when unusual bird deaths signal an emerging arbovirus.
These three strands—ecology, evolution, comparative biology—are not separate specialties within One Health so much as complementary lenses on the same phenomena. A complete account of a zoonotic disease requires all three: the ecology explains why a pathogen persists in a particular landscape; the evolution explains how it acquired the capacity to infect humans; the comparative biology explains what happens once it does.
One Health is unusual among scientific subfields in that its central innovation is as much organizational as intellectual. The field’s founders recognized that even perfect scientific understanding would be useless if no institution had the mandate to act on it. Consequently, a major portion of One Health’s energy is devoted to creating integrated surveillance and collaborative response systems.
Integrated surveillance means collecting and sharing data across human clinical networks, veterinary diagnostic laboratories, wildlife monitoring programs, and environmental sampling. In practice, this requires resolving differences in data formats, funding streams, legal authority, and professional cultures. A veterinarian reporting an unusual cluster of livestock deaths may have no existing channel to alert human public health authorities; a physician diagnosing a rare encephalitis may have no reason to ask about animal exposures. One Health interventions often begin precisely at these information gaps, building cross-reporting mechanisms, joint risk assessments, and composite early-warning systems.
A second major approach is intervention at the animal–environment interface rather than at the human bedside. If a zoonotic pathogen is amplified in livestock or persists in wildlife, the most cost-effective point of control may be animal vaccination, changes in farming practices, wildlife population management, or land-use zoning—rather than treating human cases after they occur. This is often described as primary prevention: stopping the spillover before it happens, rather than containing an outbreak after it has begun. Examples include vaccination of wildlife reservoirs for rabies, changing pig and poultry rearing practices to reduce influenza reassortment opportunities, and regulating wet markets or bushmeat trade to reduce human–wildlife contact.
A third strand is planetary health, a closely related but broader movement that situates human health within the health of all natural systems, including climate, biodiversity, and biogeochemical cycles. The relationship between One Health and planetary health is partly chronological and partly conceptual: planetary health is the more recent and more expansive framing, treating not only infectious disease but also nutrition, mental health, and chronic disease as products of ecosystem condition. One Health is often described as focusing on infectious disease and the animal–human–environment triad, while planetary health includes all of human health and all of the Earth system. In practice, the two overlap heavily; many researchers work across both, and the distinction is more a matter of emphasis than of membership.
One Health is not a unified doctrine, and its internal debates are substantive. The earliest modern formulation—One Medicine—was essentially comparative clinical science: physicians and veterinarians studying the same disease processes. A later, more powerful framing, often called ecosystem health or conservation medicine, emphasized the environment as a co-equal pillar and drew on ecology and conservation biology. More recently, the global health security framing has dominated institutional funding: it treats zoonotic emergence as a security threat and prioritizes surveillance, laboratory capacity, and rapid response, often in low- and middle-income countries where emerging pathogens are most likely to appear.
These framings are not mutually exclusive, but they emphasize different priorities. One Medicine is closest to the clinical and research sciences; ecosystem health is most attentive to biodiversity and environmental degradation; global health security is most oriented to threat assessment and outbreak response. Critics of the security framing argue that it can neglect the structural drivers of disease emergence—poverty, land inequality, industrial agriculture—in favor of technical fixes that protect wealthy countries from pathogens originating elsewhere. Critics of the ecosystem framing argue that it can understate the role of human activity and overstate wilderness as a source of risk. Defenders of each position respond that their approach does not exclude the others; the debate is largely over where scarce resources and political attention should be directed.
A second major debate concerns the role of wildlife. One common narrative attributes emerging zoonoses to human encroachment on pristine ecosystems, framing nature as a reservoir of threat. A competing account, often associated with conservation biologists, points out that the highest-risk landscapes are frequently agricultural and highly modified, and that biodiversity loss—not biodiversity itself—is correlated with disease emergence. This dispute matters practically because it determines whether interventions favor protecting intact ecosystems or regulating agricultural intensification. The evidence is not uniform across diseases, and the field has not reached a settled consensus; the more defensible generalization is that rapid environmental change, whether from deforestation, intensification, or climate shifts, is a more reliable risk factor than any particular land-use type.
A third tension is disciplinary. Human medicine, veterinary medicine, and environmental science have different epistemologies—clinical medicine is oriented to the individual patient, veterinary medicine often to herds and populations, ecology to systems and processes. One Health projects frequently struggle with these differences: a wildlife ecologist and an infectious disease physician may agree that a problem matters but disagree about what counts as evidence, what time scale is relevant, and what intervention is acceptable. The field’s institutional structures—joint appointments, cross-training, interdisciplinary funding mechanisms—are attempts to bridge these differences, but they have not eliminated them.
One Health is now an established feature of the global health architecture. Major international bodies, including the World Health Organization, the World Organisation for Animal Health, and the Food and Agriculture Organization, have formal trilateral collaborations; many national governments have One Health offices or strategies; and research funding for zoonotic disease has expanded substantially since the early 2000s. In education, most veterinary schools now include One Health coursework, and many medical and public health programs have added joint offerings. The COVID-19 pandemic, whose probable wildlife origin and massive global impact made the case for cross-species surveillance undeniable, strengthened this institutionalization further, though it also revealed how far the field is from its own aspirations: early warning systems did not detect the virus before global spread.
The contemporary research frontier is active on several fronts. Genomic epidemiology uses rapid pathogen sequencing to trace transmission networks across species in near-real time, making it possible to identify the animal source of an outbreak and to detect adaptation to human hosts as it happens. Landscape ecology and remote sensing allow researchers to model how habitat fragmentation, climate shifts, and agricultural expansion change the contact rates between species, permitting predictive mapping of spillover risk. Behavioral and social science has entered the field through the recognition that disease emergence is driven by human practices—livestock rearing, wildlife trade, land conversion, health-seeking behavior—and that interventions fail unless they are socially and economically feasible. Mathematical modeling integrates these data to estimate the basic reproduction number (\(R_0\)) of a pathogen in a new host, to compare intervention strategies, and to anticipate whether a spillover is likely to become an epidemic.
At the same time, the field’s practical limitations are as diagnostic as its achievements. Integrated surveillance systems are most advanced in wealthy countries and least developed in the regions where zoonotic emergence is most likely. Funding remains heavily skewed toward outbreak response rather than prevention. The biological sciences dominate the field’s publications and grant awards, while the social and political dimensions of disease emergence—trade networks, labor conditions, governance capacity—remain comparatively understudied despite being the actual bottlenecks in many outbreaks. And the field’s own interdisciplinary rhetoric is frequently contradicted by the single-discipline training of most of its practitioners.
These limitations do not diminish the field’s central insight, which is robust and increasingly difficult to argue with: that health is an ecological property, not a species-specific one. The most durable contribution of One Health may be less any particular discovery than the institutional recognition that human health cannot be secured by human institutions alone. Its future depends on whether that recognition can be extended from the scientific community to the systems that actually govern land use, agriculture, and trade—the systems that determine, in the first place, what crosses the species line.